WallStreetZenWallStreetZen

NASDAQ: BCAX
Bicara Therapeutics Inc Stock Ownership - Who owns Bicara Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Bicara Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Claire MazumdarChief Executive Officer2025-10-1624,103$18.83
$453.76kSell
Claire MazumdarChief Executive Officer2025-10-1624,103$3.79
$91.35kBuy
Claire MazumdarChief Executive Officer2025-10-1513,289$3.79
$50.37kBuy
Ryan CohlheppPresident and COO2025-10-154,500$18.16
$81.70kSell
Claire MazumdarChief Executive Officer2025-10-1513,289$18.84
$250.39kSell
Ryan CohlheppPresident and COO2025-10-158,000$3.79
$30.32kBuy
Ryan CohlheppPresident and COO2025-10-158,000$18.16
$145.24kSell
Claire MazumdarChief Executive Officer2025-10-1311,445$18.92
$216.55kSell
Claire MazumdarChief Executive Officer2025-10-1311,445$3.79
$43.38kBuy
David RabenChief Medical Officer2025-10-0922,000$18.45
$405.90kSell

1 of 4

BCAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BCAX insiders and whales buy or sell their stock.

BCAX Shareholders

What type of owners hold Bicara Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP12.75%6,955,993$110.46MInstitution
Kiran Mazumdarshaw11.54%6,297,854$100.01MInsider
Biocon Ltd10.12%5,523,897$87.72MInsider
Siren LLC9.56%5,216,969$82.85MInstitution
Vestal Point Capital LP9.16%5,000,000$79.40MInstitution
Red Tree Management LLC5.81%3,170,509$50.35MInstitution
Tpg GP A LLC5.52%3,010,425$47.81MInstitution
Ra Capital Management LP4.86%2,652,575$42.12MInsider
Fmr LLC4.65%2,538,404$40.31MInstitution
Deep Track Capital LP4.45%2,426,657$38.54MInstitution

1 of 3

BCAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BCAX70.82%29.18%Net SellingNet Selling
RZLT42.15%57.85%Net Buying
NBTX11.70%0.00%
TNGX60.58%39.42%Net SellingNet Selling
LENZ45.71%54.29%Net SellingNet Selling
View Top Biotech Stocks

Bicara Therapeutics Stock Ownership FAQ

Who owns Bicara Therapeutics?

Bicara Therapeutics (NASDAQ: BCAX) is owned by 93.77% institutional shareholders, 38.64% Bicara Therapeutics insiders, and 0.00% retail investors. Kiran Mazumdarshaw is the largest individual Bicara Therapeutics shareholder, owning 6.30M shares representing 11.54% of the company. Kiran Mazumdarshaw's Bicara Therapeutics shares are currently valued at $100.01M.

If you're new to stock investing, here's how to buy Bicara Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.